Papez, Maja published the artcileAnorectal drug products for over-the-counter human use, Formula: C17H28ClNO3, the publication is Federal Register (2003), 68(165), 51167-51170, database is CAplus.
The Food and Drug Administration (FDA) is issuing, under the Federal Food, Drug, and Cosmetic Act, a final rule establishing that any over-the-counter (OTC) drug product containing a combination of hydrocortisone and pramoxine hydrochloride (HCl) for anorectal use is not generally recognized as safe and effective and is misbranded. This combination product is not currently marketed OTC. This final rule discusses data on the combination of hydrocortisone and pramoxine HCl that were still under review when an earlier final rule on OTC anorectal drug products was issued. This rule is part of FDA’s ongoing review of OTC drug products.
Federal Register published new progress about 637-58-1. 637-58-1 belongs to ethers-buliding-blocks, auxiliary class Inhibitor, name is 4-(3-(4-Butoxyphenoxy)propyl)morpholine hydrochloride, and the molecular formula is C10H13NO2, Formula: C17H28ClNO3.
Referemce:
https://en.wikipedia.org/wiki/Ether,
Ether | (C2H5)2O – PubChem